CRTX — CRISM' Therapeutics Share News
0.000.00%
Last trade - 00:00- £3.35m
- £1.48m
REG - CRISM Therapeutics - Notice of Interim Results and IMC Presentation
AnnouncementREG - CRISM Therapeutics - Approval for phase 2 clinical trial
AnnouncementREG - CRISM Therapeutics - Result of AGM
AnnouncementREG - CRISM Therapeutics - AGM Statement
AnnouncementREG - CRISM Therapeutics - GMP Manufacture of ChemoSeed
AnnouncementREG - CRISM Therapeutics - Notice of AGM and EMI Option Plan
AnnouncementREG - CRISM Therapeutics - Holding(s) in Company
AnnouncementREG - CRISM Therapeutics - Result of Retail Offer and Additional Placing
AnnouncementRCS - CRISM Therapeutics - Update presentation on the IMC platform
AnnouncementREG - CRISM Therapeutics - Submission of CTA Application
AnnouncementREG - CRISM Therapeutics - Retail Offer
AnnouncementREG - CRISM Therapeutics - Placing
AnnouncementREG - CRISM Therapeutics - Final Results for the year ended 31 December 2024
AnnouncementRCS - CRISM Therapeutics - Best Paper Award
AnnouncementREG - CRISM Therapeutics - Establishment of Scientific Advisory Board
AnnouncementREG - CRISM Therapeutics - Director Dealing
AnnouncementREG - CRISM Therapeutics - Clinical Trial Update
AnnouncementREG - CRISM Therapeutics - Innovate UK Grant Award
AnnouncementREG - CRISM Therapeutics - Appointment of Specialist Clinical CRO
Announcement